Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes-related complications-Reference-Cited by-同舟云学术

Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes-related complications

Published:2008-06 Issue:s1 Volume:10 Page:33-42
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Chen J.,Alemao E.,Yin D.,Cook J.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2008.00885.x/fullpdf

Reference29 articles.

1. 1 American Diabetes Association Standards of medical care for patients with diabetes mellitus . Diabetes Care, 2003 ; 26 (Suppl. 1 ): S33 -S50 .

2. 3 International Diabetes Federation IDF Clinical Guidelines Task Force: Global Guideline for Type 2 Diabetes . , 2005 . Available from URL: www.idf.org/webdata/docs/IDF%20GGT2D.pdf. Accessed 2 July 2007.

3. Rimonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes: reply

4. Quality of Diabetes Care in U.S. Academic Medical Centers

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of complications in health economic models of type 2 diabetes: a review of methods used;Acta Diabetologica;2023-03-03

2. A Promising Approach to Optimizing Sequential Treatment Decisions for Depression: Markov Decision Process;PharmacoEconomics;2022-09-14

3. A review of simulation models for the long-term management of type 2 diabetes in low-and-middle income countries;BMC Health Services Research;2021-12

4. The impact of energy retrofits on pediatric asthma exacerbation in a Boston multi-family housing complex: a systems science approach;Environmental Health;2021-02-14

5. Patient-level micro-simulation model for evaluating the future potential cost–effectiveness of pharmacy-based interventions in the control and management of diabetes-related complications in Canada;2020-03-13